Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 9;121(15):e2321502121.
doi: 10.1073/pnas.2321502121. Epub 2024 Apr 2.

Transcriptional elongation control of hypoxic response

Affiliations

Transcriptional elongation control of hypoxic response

Shimaa Hassan AbdelAziz Soliman et al. Proc Natl Acad Sci U S A. .

Abstract

The release of paused RNA polymerase II (RNAPII) from promoter-proximal regions is tightly controlled to ensure proper regulation of gene expression. The elongation factor PTEF-b is known to release paused RNAPII via phosphorylation of the RNAPII C-terminal domain by its cyclin-dependent kinase component, CDK9. However, the signal and stress-specific roles of the various RNAPII-associated macromolecular complexes containing PTEF-b/CDK9 are not yet clear. Here, we identify and characterize the CDK9 complex required for transcriptional response to hypoxia. Contrary to previous reports, our data indicate that a CDK9 complex containing BRD4 but not AFF1/4 is essential for this hypoxic stress response. We demonstrate that BRD4 bromodomains (BET) are dispensable for the release of paused RNAPII at hypoxia-activated genes and that BET inhibition by JQ1 is insufficient to impair hypoxic gene response. Mechanistically, we demonstrate that the C-terminal region of BRD4 is required for Polymerase-Associated Factor-1 Complex (PAF1C) recruitment to establish an elongation-competent RNAPII complex at hypoxia-responsive genes. PAF1C disruption using a small-molecule inhibitor (iPAF1C) impairs hypoxia-induced, BRD4-mediated RNAPII release. Together, our results provide insight into potentially targetable mechanisms that control the hypoxia-responsive transcriptional elongation.

Keywords: RNA polymerase II; chromatin; epigenetic mechanisms; gene expression; transcription.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

Similar articles

References

    1. Giaccia A. J., Simon M. C., Johnson R., The biology of hypoxia: The role of oxygen sensing in development, normal function, and disease. Genes. Dev. 18, 2183–2194 (2004). - PMC - PubMed
    1. Lee P., Chandel N. S., Simon M. C., Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell Biol. 21, 268–283 (2020). - PMC - PubMed
    1. Semenza G. L., Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7, 345–350 (2001). - PubMed
    1. Smith T. G., Robbins P. A., Ratcliffe P. J., The human side of hypoxia-inducible factor. Br J. Haematol. 141, 325–334 (2008). - PMC - PubMed
    1. Wang G. L., et al. , Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510–5514 (1995). - PMC - PubMed

MeSH terms

LinkOut - more resources

-